<PAPER><mode2 name='PMC4662295' hasDoc='yes' version='597'></mode2><article xmlns:mml='http://www.w3.org/1998/Math/MathML' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:ali='http://www.niso.org/schemas/ali/1.0' article-type='research-article'><front><journal-meta><journal-id journal-id-type='nlm-ta'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='iso-abbrev'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='publisher-id'>DEE</journal-id><journal-title-group><journal-title>Dementia and Geriatric Cognitive Disorders EXTRA</journal-title></journal-title-group><issn pub-type='ppub'>1664-5464</issn><issn pub-type='epub'>1664-5464</issn><publisher><publisher-name>S. Karger AG</publisher-name><publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type='pmcid'>4662295</article-id><article-id pub-id-type='doi'>10.1159/000438857</article-id><article-id pub-id-type='publisher-id'>dee-0005-0404</article-id><article-categories><subj-group subj-group-type='heading'><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title><s sid='1'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1><CoreSc2 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc2>Quantitative Electroencephalography as a Diagnostic Tool for Alzheimer's Dementia in Adults with Down Syndrome</s></article-title></title-group><contrib-group><contrib contrib-type='author'><name><surname>Salem</surname><given-names>Lise Cronberg</given-names></name><xref rid='aff1' ref-type='aff'>a</xref><xref rid='cor1' ref-type='corresp'>*</xref></contrib><contrib contrib-type='author'><name><surname>Sabers</surname><given-names>Anne</given-names></name><xref rid='aff2' ref-type='aff'>b</xref></contrib><contrib contrib-type='author'><name><surname>Kjaer</surname><given-names>Troels W.</given-names></name><xref rid='aff5' ref-type='aff'>e</xref></contrib><contrib contrib-type='author'><name><surname>Musaeus</surname><given-names>Christian</given-names></name><xref rid='aff1' ref-type='aff'>a</xref></contrib><contrib contrib-type='author'><name><surname>Nielsen</surname><given-names>Martin N.</given-names></name><xref rid='aff3' ref-type='aff'>c</xref></contrib><contrib contrib-type='author'><name><surname>Nielsen</surname><given-names>Anne-Grete</given-names></name><xref rid='aff4' ref-type='aff'>d</xref></contrib><contrib contrib-type='author'><name><surname>Waldemar</surname><given-names>Gunhild</given-names></name><xref rid='aff1' ref-type='aff'>a</xref></contrib></contrib-group><aff id='aff1'><sup>a</sup>Danish Dementia Research Centre, Copenhagen University Hospital, Rigshospitalet, Denmark</aff><aff id='aff2'><sup>b</sup>Epilepsy Clinic, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Denmark</aff><aff id='aff3'><sup>c</sup>Department of Clinical Neurophysiology, Copenhagen University Hospital, Rigshospitalet, Denmark</aff><aff id='aff4'><sup>d</sup>Centre for Seniors with Disabilities, Copenhagen, Denmark</aff><aff id='aff5'><sup>e</sup>Neurophysiology Center, Roskilde University Hospital, Roskilde, Denmark</aff><author-notes><corresp id='cor1'>*Lise Cronberg Salem, MD, PhD, Memory Disorders Research Group, Danish Dementia Research Centre, Copenhagen University Hospital, Rigshospitalet, Section 6991, Blegdamsvej 9, DK-2100 Copenhagen (Denmark), E-Mail <email>Lise.cronberg.salem.01@regionh.dk</email></corresp></author-notes><pub-date pub-type='collection'><season>Sep-Dec</season><year>2015</year></pub-date><pub-date pub-type='epub'><day>21</day><month>10</month><year>2015</year></pub-date><pub-date pub-type='pmc-release'><day>21</day><month>10</month><year>2015</year></pub-date><volume>5</volume><issue>3</issue><fpage>404</fpage><lpage>413</lpage><history><date date-type='rev-recd'><day>20</day><month>7</month><year>2015</year></date></history><permissions><copyright-statement>Copyright © 2015 by S. Karger AG, Basel</copyright-statement><copyright-year>2015</copyright-year><license license-type='open-access' xlink:href='http://creativecommons.org/licenses/by-nc/3.0/'><license-p>This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.</license-p></license></permissions><abstract><sec><title>Background</title><p><s sid='2'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Assessment of dementia in individuals with intellectual disability is complex due to great inter-individual variability in cognitive function prior to dementia and a lack of standardized instruments.</s><s sid='3'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Studies have indicated that quantitative electroencephalography (qEEG) results may be used as a diagnostic marker for dementia.</s><s sid='4'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1> The aim of this study was to examine the value of qEEG in the diagnostic evaluation of dementia in patients with Down syndrome (DS).</s></p></sec><sec><title>Method</title><p><s sid='5'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>The study included 21 patients with DS and mild-to-moderate dementia due to Alzheimer's disease (DS-AD) and 16 age-matched adults with DS without cognitive deterioration assessed by the informant-based Dementia Screening Questionnaire in Intellectual Disability (DSQIID).</s><s sid='6'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Conventional EEG was performed and analysed quantitatively using fast Fourier transformation.</s><s sid='7'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Outcomes were centroid frequency, peak frequency, absolute power, and relative power.</s></p></sec><sec><title>Results</title><p><s sid='8'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>In several regions of the brain, a significant decrease in the theta-1 band (4-7 Hz) was identified for the centroid frequency.</s><s sid='9'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> A significant negative correlation was demonstrated between the mean of the centroid frequency of the theta-1 band and the total DSQIID score.</s></p></sec><sec><title>Conclusion</title><p><s sid='10'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>We found that qEEG can detect a significant decrease in centroid frequency in a sample of patients with DS-AD as compared to a sample of adults with DS and no cognitive deterioration.</s></p></sec></abstract><kwd-group><title>Key Words</title><kwd>Down syndrome</kwd><kwd>Diagnostic assessment</kwd><kwd>Quantitative electroencephalography</kwd><kwd>Alzheimer's dementia</kwd></kwd-group><counts><fig-count count='4'></fig-count><table-count count='1'></table-count><ref-count count='30'></ref-count><page-count count='10'></page-count></counts></article-meta></front><body><sec sec-type='intro' id='sec1_1'><title>Introduction</title><p><s sid='11'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>In developed countries, the population of elderly people with Down syndrome (DS) is expanding, resulting in an increasing incidence of age-related diseases including dementia [<xref rid='B1' ref-type='bibr'>1</xref>,<xref rid='B2' ref-type='bibr'>2</xref>].</s><s sid='12'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> DS is the most common chromosomal defect leading to mental retardation, with an incidence of approximately 1 in 650-1,000 live births worldwide [<xref rid='B1' ref-type='bibr'>1</xref>].</s><s sid='13'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> It is caused by trisomy of chromosome 21 and is associated with physical, psychiatric, and neurological complications.</s><s sid='14'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Neuritic amyloid-β plaques and neurofibrillary tangles – characteristic neuropathological features of Alzheimer's disease (AD) – are a virtually certain finding in the brains of adults with DS, and have even been noted in some children with DS [<xref rid='B3' ref-type='bibr'>3</xref>,<xref rid='B4' ref-type='bibr'>4</xref>,<xref rid='B5' ref-type='bibr'>5</xref>,<xref rid='B6' ref-type='bibr'>6</xref>].</s><s sid='15'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The earliest accumulation appears to be in the frontal and temporal lobes [<xref rid='B6' ref-type='bibr'>6</xref>].</s><s sid='16'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The increased risk of AD in DS is primarily attributed to a gene found on chromosome 21, amyloid precursor protein, although the trigger for development of dementia is unknown [<xref rid='B7' ref-type='bibr'>7</xref>].</s><s sid='17'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> It is estimated that, clinically, dementia can be diagnosed in only some 9% of adults with DS in their 4th decade and around 55% in their 6th decade of life [<xref rid='B8' ref-type='bibr'>8</xref>].</s><s sid='18'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Another study has estimated that nearly 20% of individuals with DS aged 45 years and more have dementia due to AD (DS-AD), and several studies have shown a greater risk of early mortality for people with DS and dementia [<xref rid='B6' ref-type='bibr'>6</xref>,<xref rid='B9' ref-type='bibr'>9</xref>,<xref rid='B10' ref-type='bibr'>10</xref>,<xref rid='B11' ref-type='bibr'>11</xref>,<xref rid='B12' ref-type='bibr'>12</xref>].</s><s sid='19'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> However, the incidence rate of dementia is associated with uncertainty, as the diagnosis of dementia in people with DS remains difficult, particularly in the early stage of the disease.</s></p><p><s sid='20'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The assessment of dementia in individuals with intellectual disability is often complex due to great inter-individual variability in cognitive functioning prior to dementia and a lack of standardized measures to detect dementia.</s><s sid='21'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The ability to cooperate in relation to the successful completion of standard physical examinations, brain imaging, and other investigatory tests is often impaired due to intellectual disability [<xref rid='B13' ref-type='bibr'>13</xref>,<xref rid='B14' ref-type='bibr'>14</xref>].</s><s sid='22'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The diagnostic assessment may be further complicated due to the fact that social and cognitive abilities often are underdeveloped and comorbidity of hypothyroidism and depression is relatively common [<xref rid='B13' ref-type='bibr'>13</xref>].</s><s sid='23'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> To circumvent these problems, it is recommended that neuropsychological testing of a patient should be combined with informant-based rating scales.</s></p><p><s sid='24'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Quantitative electroencephalography (qEEG) is the analysis of various features of conventional EEGs to derive metrics and visual displays through digital methods.</s><s sid='25'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The electrical activity is quantified with a variety of statistical measures to characterize the huge variation in combinations of emissions from the brain.</s><s sid='26'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Studies have shown that AD leads to increasing slow-wave activity of the EEG (an increase in theta and delta wave activity) and enhanced complexity of the EEG signals [<xref rid='B15' ref-type='bibr'>15</xref>].</s><s sid='27'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In adults with DS without dementia, it has been established that an age-related slowing of the alpha rhythm may develop at an earlier age as compared to healthy adults of the general population [<xref rid='B16' ref-type='bibr'>16</xref>].</s><s sid='28'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> However, to our knowledge there are no reports comparing qEEG results in patients with DS with and without AD.</s><s sid='29'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> It is possible that EEG, an atraumatic investigation, may contribute to the early diagnosis of AD in DS.</s></p><p><s sid='30'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>The aim of the present study was to examine the value of qEEG in the diagnostic evaluation of dementia in patients with DS.</s><s sid='31'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1> We hypothesized an increase in delta and theta wave activity of the qEEG recordings in patients with DS and AD globally as compared to people with DS without AD.</s></p></sec><sec sec-type='subjects|methods' id='sec1_2'><title>Subjects and Methods</title><p><s sid='32'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>This study was designed as an explorative case-control study on qEEG as a diagnostic tool in patients with DS and possible dementia due to AD.</s></p><sec id='sec2_1'><title>Sample</title><p><s sid='33'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Patients with DS and cognitive decline were recruited from the Copenhagen University Hospital Memory Clinic at Rigshospitalet, which is a multidisciplinary outpatient clinic based in the Department of Neurology.</s><s sid='34'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Referrals are received from general practitioners, specialists, and other hospitals.</s></p><p><s sid='35'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>The control subjects were adults with DS recruited from recreational homes for adults with intellectual disabilities in the Copenhagen area.</s><s sid='36'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> An administrative specialized nurse supervising the institutions contacted the manager of each institution, asking for permission to contact potential participants according to the inclusion criteria applied for this study.</s></p><p><s sid='37'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>The inclusion criteria for both patients and control subjects were: (1) karyotype examination confirming trisomy of chromosome 21; (2) ability to cooperate (leading to exclusion of participants with severe intellectual disability); (3) age above 35 years, and (4) fulfilling the criteria for probable AD.</s><s sid='38'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The exclusion criterion for patients and control subjects was a mis- or under-treated medical (assessed by blood tests and clinical appearance) or psychiatric condition (assessed clinically by the neurologist) that might influence cognition (e.g. hypothyroidism and depression).</s></p><p><s sid='39'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>We recruited 21 patients with DS and AD and 16 age-matched control subjects with DS and no cognitive decline.</s><s sid='40'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Cognitive decline was assessed using the informant-based Dementia Screening Questionnaire in Intellectual Disability (DSQIID) [<xref rid='B17' ref-type='bibr'>17</xref>].</s><s sid='41'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> One patient and 2 control subjects were living at home, attending a supervised workshop, while the remaining patients and control subjects were institutionalized.</s></p><p><s sid='42'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Informed consent was obtained from the personal legal guardian, or, if no legal guardian was assigned, from the family doctor.</s><s sid='43'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The subjects and caregivers were informed that they could request the interruption of the clinical and instrumental procedures at any time.</s></p></sec><sec id='sec2_2'><title>Diagnostic Workup of the Patients</title><p><s sid='44'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>The dementia diagnosis was established based on the following assessments:</s></p><list list-type='order'><list-item><p><s sid='45'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>A detailed history of medical, neurological, and psychiatric conditions, including a review of the medical records, to establish past and present physical and/or mental health disorders</s></p></list-item><list-item><p><s sid='46'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>A history of symptoms of dementia from family members and/or caregivers</s></p></list-item><list-item><p><s sid='47'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Information on the current intake of medicine</s></p></list-item><list-item><p><s sid='48'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Screening for dementia symptoms using the DSQIID [<xref rid='B17' ref-type='bibr'>17</xref>], an informant-based questionnaire; a high score (&gt;20) indicates a high level of cognitive decline; this screening instrument has been proved to be a valid and reliable observer-rated questionnaire for screening for dementia among adults with DS</s></p></list-item><list-item><p><s sid='49'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Physical and neurological examinations including a comprehensive screening for visual and hearing impairment</s></p></list-item><list-item><p><s sid='50'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Psychiatric assessment of symptoms of depression (when relevant)</s></p></list-item><list-item><p><s sid='51'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>A full panel of blood tests recommended as part of the diagnostic workup of dementia according to international clinical guidelines available in 2013 [<xref rid='B18' ref-type='bibr'>18</xref>]</s></p></list-item><list-item><p><s sid='52'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Confirmation of genetic status (trisomy 21) from the medical records</s></p></list-item><list-item><p><s sid='53'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>CT scanning of the brain if the patient was able to cooperate</s></p></list-item><list-item><p><s sid='54'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Additional examinations (when found relevant)</s></p></list-item></list><p><s sid='55'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Subsequently, the diagnosis of dementia was established according to the ICD-10 [<xref rid='B19' ref-type='bibr'>19</xref>] and/or DSM-IV criteria [<xref rid='B20' ref-type='bibr'>20</xref>].</s><s sid='56'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The diagnosis of AD was established according to the criteria of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) for probable AD [<xref rid='B21' ref-type='bibr'>21</xref>], supported by the ICD-10 Symptom Checklist for Mental Disorders and guidelines set by an international consensus panel associated with the International Association for the Scientific Study of Intellectual Disabilities (IASSID) [<xref rid='B22' ref-type='bibr'>22</xref>].</s><s sid='57'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> After completion of the diagnostic workup, the multidisciplinary staff (dementia specialists, neuropsychologists, and specialist nurses) established a consensus diagnostic classification.</s><s sid='58'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The patients with DS-AD included in this study were estimated to be in a mild-to-moderate phase of their dementia disorder.</s><s sid='59'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Each control subject with DS included in this study was examined at baseline according to items 1-8.</s></p></sec><sec id='sec2_3'><title>Electroencephalography</title><p><s sid='60'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Electroencephalograms were recorded using Nicolet One EEG (Nervus) recording software 5.82 (Natus) with a standard 44-channel head box, and each subject was fitted with a cap using silver-silver-chloride-coated electrodes.</s><s sid='61'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The electroencephalogram was recorded in a 30-min period in subjects in the wake resting state from 19 electrodes positioned according to the International 10-20 system (i.e. Fp1, Fp2, F3, Fz, F4, F7, F8, T3, T4, C3, Cz, C4, T5, T6, P3, Pz, P4, O1, O2).</s><s sid='62'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Data were sampled at 1.0 kHz and bandpass filtered at 0.5-70.0 Hz.</s><s sid='63'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> To monitor eye movements and heart rhythm, electrooculograms and electrocardiograms (0.3-70 Hz bandpass) were collected.</s><s sid='64'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The status of handedness for every participant was established using the Edinburgh inventory [<xref rid='B23' ref-type='bibr'>23</xref>].</s></p><p><s sid='65'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>Special attention was devoted to obtaining maximal relaxation and cooperation of the subjects, to obtaining high-quality EEG recordings, and to avoiding well-known effects of stress and anxiety.</s><s sid='66'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> An experienced neurophysiologist (T.W.K.) analysed the conventional electroencephalograms blindly, unaware of the clinical data on the subjects.</s><s sid='67'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The recorded EEG data were then fragmented off-line in consecutive epochs of a minimum of 4 s by a medical student (C.M.), also blinded to the clinical data on the patients.</s><s sid='68'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> For each subject, up to 10 epochs were carefully selected for analysis.</s><s sid='69'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> However, in some cases the subjects were unable to lie still, resulting in artefacts on EEG and less than 10 epochs suitable for analysis.</s><s sid='70'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> None of the EEG recordings revealed paroxysmal activity.</s><s sid='71'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Seven frequency bands were determined for analysis: delta (0.5-3.5 Hz), theta-1 (4-7 Hz), theta-2 (5-6 Hz), theta-3 (5-7 Hz), theta-alpha-1 (5-10 Hz), theta-alpha-2 (4-13 Hz), alpha (8-13 Hz), and beta (≥14 Hz).</s></p></sec><sec id='sec2_4'><title>Quantitative EEG</title><p><s sid='72'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>qEEG spectral analysis was performed using digital fast Fourier transformation and power spectral density (PSD) determination with the Welch method (Hamming window function, 75% overlap, and 4-second window length).</s><s sid='73'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Four qEEG parameters were derived from the PSD: centroid frequency, peak frequency, absolute power, and relative power.</s><s sid='74'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> An illustration of the qEEG outcome is shown in figure <xref rid='F1' ref-type='fig'>1</xref>.</s><s sid='75'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Determined by PSD, centroid frequency was defined as the weighted mean of the frequencies present in the EEG epoch, using their magnitudes as weights.</s><s sid='76'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Peak frequency was defined as the peak frequency in the respective epoch, channel, and frequency band with highest magnitude in the PSD.</s><s sid='77'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Absolute power was defined as the total power in each epoch, channel, and frequency band normalized to 1 s.</s><s sid='78'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Relative power was defined as the relative power in each frequency band compared to the total power in all frequency bands, in each epoch and channel.</s></p><p><s sid='79'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>All qEEG parameters were computed for each epoch, for all channels, and in all selected frequency bands using a MATLAB-based GUI program developed for this study.</s></p></sec><sec id='sec2_5'><title>Ethics</title><p><s sid='80'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>This study was approved by the local ethics committee (J.nr.</s><s sid='81'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> H-4-2012-111) and the Danish Data Protection Agency (J.nr.</s><s sid='82'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> 2007-58-0015).</s></p></sec><sec id='sec2_6'><title>Statistical Analysis</title><p><s sid='83'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The level of significance in group-by-group comparisons was investigated with the independent sample t test for quantitative variables with a normal distribution.</s><s sid='84'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The Mann-Whitney U test was used for group-by-group comparisons with a skewed distribution of the data.</s><s sid='85'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The χ<sup>2</sup> test was used on nominal variables, and Fischer's exact test (two-sided) was applied when cells had expected counts of less than 5.</s><s sid='86'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A linear regression model was used to assess the impact of centroid frequency, peak frequency, absolute power, and relative power in the theta-1 band on DSQIID score, with plots of residuals as a model control.</s><s sid='87'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The false discovery rate was used to correct for multiple comparisons.</s><s sid='88'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The data were analysed using SPSS 19.0 for Windows (SPSS Inc., Chicago, Ill., USA).</s></p></sec></sec><sec sec-type='results' id='sec1_3'><title>Results</title><sec id='sec2_7'><title>Clinical Data</title><p><s sid='89'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>The clinical data are shown in table <xref rid='T1' ref-type='table'>1</xref>.</s><s sid='90'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> As expected, total scores on the DSQIID were significantly different between patients and control subjects (U = 0.0, z = −5.17, p &lt; 0.001), as the highest score was found in the DS-AD group.</s><s sid='91'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> No significant group differences were found in age and sex ratios between patients and control subjects.</s></p></sec><sec id='sec2_8'><title>Mean Scores of Centroid Frequency Globally for Every Frequency Band for the Two Study Groups</title><p><s sid='92'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Mean scores of centroid frequency, mean frequency, absolute power, and relative power of every frequency band in patients were compared to those in control subjects.</s><s sid='93'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The centroid frequency for the theta-1 band was significantly decreased in several areas of the brain – primarily frontotemporal, on the left side – in patients with DS-AD as compared to control subjects (fig. <xref rid='F2' ref-type='fig'>2</xref>).</s><s sid='94'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> This was specifically the case in the theta-1 band for Fp1-F7 [(t = 35) = 2.681, p = 0.001] and F7-T3 (U = 82, z = −2.64, p = 0.008, r = 0.43).</s><s sid='95'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The false discovery rate was used to correct for multiple comparisons leading to insignificant p values for all frequency bands.</s><s sid='96'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> To visualize the negative correlation between the mean of the centroid frequency of the theta-1 band in the left frontotemporal region (F7-T3) and the total score on the DSQIID, a scatterplot was generated (fig. <xref rid='F3' ref-type='fig'>3</xref>).</s></p><p><s sid='97'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>No significant differences were found for the remaining variables (peak frequency, absolute power, or relative power) globally between patients and control subjects in any of the included frequency bands.</s></p><p><s sid='98'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Four patients were left-handed.</s><s sid='99'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> These patients were assumed right-hemisphere dominant, while the rest were considered left-hemisphere dominant.</s><s sid='100'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> All data were re-analysed with a dominance laterality covariate.</s><s sid='101'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> This did not change any conclusions.</s></p></sec><sec id='sec2_9'><title>Correlation between qEEG Variables Globally and Total Score on the DSQIID</title><p><s sid='102'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>When the mean of the centroid frequency of the theta-1 band at F7-T3 was entered into a stepwise linear regression model of the DSQIID, the total variance explained by the model as a whole was 32% of the variance in DSQIID score [F(2, 34) = 7.98, p &lt; 0.001].</s><s sid='103'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Figure <xref rid='F4' ref-type='fig'>4</xref> shows Pearson's correlation coefficients of the mean of the centroid frequency of the theta-1 band for all the regions investigated, and a shift in colour from blue to red indicates an increasing correlation coefficient.</s><s sid='104'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Interestingly, a correlation of 52% or higher between centroid frequency for the theta-1 band and the level of symptoms of dementia was seen globally in the brain and most prominent in the left frontotemporal region.</s><s sid='105'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> These results indicate that increasing cognitive impairment is correlated to a decrease in centroid frequency in the theta-1 band globally.</s></p></sec></sec><sec sec-type='discussion' id='sec1_4'><title>Discussion</title><p><s sid='106'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>To our knowledge, this is the first study to examine the diagnostic value of qEEG in a clinical setting in patients with DS-AD as compared to adults with DS and no cognitive decline.</s><s sid='107'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Our results show a significant decrease in centroid frequency in the theta-1 band in patients with DS-AD in several regions of the brain (fig. <xref rid='F2' ref-type='fig'>2</xref>).</s><s sid='108'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Furthermore, we have demonstrated a significant correlation between high scores on the DSQIID and lower frequency of the qEEG variable centroid frequency in the theta-1 band globally and, most pronounced, in the left frontotemporal region.</s><s sid='109'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> These results are unique, but they may be biased by the relatively small study population and by the fact that patients with DS-AD on average were 4 years older than control subjects.</s><s sid='110'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> As higher age is associated with a higher incidence of symptoms of dementia and slowing of the EEG, this is a confounding factor to be taken into consideration.</s><s sid='111'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Furthermore, correcting for multiple comparisons using the false discovery rate resulted in a non-significant decrease in centroid frequency.</s></p><p><s sid='112'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>The decrease in centroid frequency in the theta-1 band is in accordance with previous findings showing an increased slow-wave activity of the delta and theta frequency bands in adults with DS-AD as compared to healthy adults [<xref rid='B24' ref-type='bibr'>24</xref>,<xref rid='B25' ref-type='bibr'>25</xref>].</s><s sid='113'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> A number of studies have previously demonstrated an association between EEG abnormalities and AD in adults with DS.</s><s sid='114'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Visser et al. [<xref rid='B25' ref-type='bibr'>25</xref>] showed, in a prospective setting, a decrease in frequency of the dominant occipital activity at the onset of cognitive deterioration, in agreement with Soininen et al. [<xref rid='B24' ref-type='bibr'>24</xref>], who found significantly more slow-wave activity (theta and delta) in patients with DS-AD as compared to healthy control subjects without DS.</s><s sid='115'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Both studies used adults without intellectual disabilities as control subjects, and because of this, it cannot be determined whether the results found were due to DS, AD, or a combination of the two.</s><s sid='116'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> This study used controls with DS and thereby allowed the effect of AD to be better examined.</s><s sid='117'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Adults with DS without cognitive deterioration have been shown in several studies to have abnormal EEG results characterized by the absence of a normal alpha rhythm [<xref rid='B26' ref-type='bibr'>26</xref>,<xref rid='B27' ref-type='bibr'>27</xref>].</s><s sid='118'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Therefore, in order to be able to separate patients with DS-AD from adults with DS with cognitive impairment due to other causes, we found it preferable in a clinical setting as a first step to compare results of qEEG in patients with DS-AD to those in other adults with DS without cognitive deterioration.</s></p><p><s sid='119'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>In adults with intellectual disabilities, a large inter-individual variability in cognitive and functional abilities is present, premorbid levels of cognitive functioning are generally unknown, and their ability to cooperate in diagnostic assessments, including cognitive testing, is often impaired, leading to a low validity of these tests [<xref rid='B13' ref-type='bibr'>13</xref>,<xref rid='B28' ref-type='bibr'>28</xref>].</s><s sid='120'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> As a consequence, all participants of this study were screened for dementia symptoms using an informant-based assessment tool, the DSQIID [<xref rid='B17' ref-type='bibr'>17</xref>].</s><s sid='121'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> We found a significant correlation between centroid frequency and total score on the DSQIID, most pronounced in the left frontotemporal region (fig. <xref rid='F3' ref-type='fig'>3</xref>).</s><s sid='122'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> This correlation may indicate a decreasing frequency of EEG recordings related to cell death in these areas due to accumulating amyloid plaques and neurofibrillary tangles.</s><s sid='123'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> These findings are related to previous findings on patterns of neuropathological changes in elderly adults with DS [<xref rid='B5' ref-type='bibr'>5</xref>,<xref rid='B6' ref-type='bibr'>6</xref>,<xref rid='B29' ref-type='bibr'>29</xref>].</s><s sid='124'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Mann [<xref rid='B5' ref-type='bibr'>5</xref>] found that these neuropathological findings in adults with DS beyond 40 years of age primarily involved the amygdala, hippocampus, and association areas of the frontal, temporal, and parietal cortices.</s></p><p><s sid='125'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>As shown in figure <xref rid='F3' ref-type='fig'>3</xref>, there is an overlap between adults with DS with dementia and those without dementia in the 5.5- to 6.5-Hz frequency bands.</s><s sid='126'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Based on the small sample size, it is not possible to determine a cutoff value.</s><s sid='127'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Presumably, larger study population is needed to clarify this issue.</s></p><p><s sid='128'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Our results indicating a dominant decrease in centroid frequency on the left side are not supported by previous studies and may be coincidental.</s><s sid='129'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Theoretically, they could be related to symptoms of aphasia associated with the left temporal lobe.</s><s sid='130'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Aphasia may be a symptom of dementia and may lead patients to diagnostic evaluation [<xref rid='B30' ref-type='bibr'>30</xref>].</s></p><p><s sid='131'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Neurophysiological assessments of brain activity have been undertaken to aid the clinical diagnosis of dementia in adults with intellectual disability due to the poor validity of neuropsychological measures for detecting cognitive deterioration in this population [<xref rid='B13' ref-type='bibr'>13</xref>].</s><s sid='132'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> As conventional EEG recordings are non-invasive, EEG may serve as a potential diagnostic tool and as a predictor of AD suitable for patients with intellectual disabilities.</s><s sid='133'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Furthermore, EEG recordings are inexpensive, potentially mobile, and relatively well tolerated.</s><s sid='134'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> All participants of our study were able to complete a conventional EEG examination.</s></p><p><s sid='135'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>In conclusion, we found that qEEG can detect a significant decrease in centroid frequency in a sample of patients with DS-AD as compared to a sample of adults with DS and no cognitive deterioration.</s><s sid='136'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> This is a unique finding, calling for further elaboration and larger studies in order to define possible cutoff values and clinical implications.</s><s sid='137'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Further studies are needed to elaborate these aspects.</s></p></sec><sec id='sec1_5'><title>Disclosure Statement</title><p>The authors have no actual or potential conflicts of interest to declare.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to thank the Danish Research Foundation for a scholarship to L.C.S. as well as the Danish Health Foundation and the Danish Ministry of Health for support of the Danish Dementia Research Centre.</p></ack><ref-list><title>References</title><ref id='B1'><label>1</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bittles</surname><given-names>AH</given-names></name><name><surname>Bower</surname><given-names>C</given-names></name><name><surname>Hussain</surname><given-names>R</given-names></name><name><surname>Glasson</surname><given-names>EJ</given-names></name></person-group><article-title>The four ages of Down syndrome</article-title><source>Eur J Public Health</source><year>2007</year><volume>17</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type='pmid'>16857692</pub-id></element-citation></ref><ref id='B2'><label>2</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Holland</surname><given-names>AJ</given-names></name></person-group><article-title>Ageing and learning disability</article-title><source>Br J Psychiatry</source><year>2000</year><volume>176</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type='pmid'>10789322</pub-id></element-citation></ref><ref id='B3'><label>3</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Olson</surname><given-names>MI</given-names></name><name><surname>Shaw</surname><given-names>CM</given-names></name></person-group><article-title>Presenile dementia and Alzheimer's disease in mongolism</article-title><source>Brain</source><year>1969</year><volume>92</volume><fpage>147</fpage><lpage>156</lpage><pub-id pub-id-type='pmid'>4237656</pub-id></element-citation></ref><ref id='B4'><label>4</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Wilcock</surname><given-names>DM</given-names></name><name><surname>Griffin</surname><given-names>WS</given-names></name></person-group><article-title>Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis</article-title><source>J Neuroinflammation</source><year>2013</year><volume>10</volume><fpage>84</fpage><pub-id pub-id-type='pmid'>23866266</pub-id></element-citation></ref><ref id='B5'><label>5</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Mann</surname><given-names>DM</given-names></name></person-group><article-title>The pathological association between Down syndrome and Alzheimer disease</article-title><source>Mech Ageing Dev</source><year>1988</year><volume>43</volume><fpage>99</fpage><lpage>136</lpage><pub-id pub-id-type='pmid'>2969441</pub-id></element-citation></ref><ref id='B6'><label>6</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Zigman</surname><given-names>WB</given-names></name><name><surname>Lott</surname><given-names>IT</given-names></name></person-group><article-title>Alzheimer's disease in Down syndrome: neurobiology and risk</article-title><source>Ment Retard Dev Disabil Res Rev</source><year>2007</year><volume>13</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type='pmid'>17910085</pub-id></element-citation></ref><ref id='B7'><label>7</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Schupf</surname><given-names>N</given-names></name><name><surname>Sergievsky</surname><given-names>GH</given-names></name></person-group><article-title>Genetic and host factors for dementia in Down's syndrome</article-title><source>Br J Psychiatry</source><year>2002</year><volume>180</volume><fpage>405</fpage><lpage>410</lpage><pub-id pub-id-type='pmid'>11983636</pub-id></element-citation></ref><ref id='B8'><label>8</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Prasher</surname><given-names>VP</given-names></name><name><surname>Filer</surname><given-names>A</given-names></name></person-group><article-title>Behavioural disturbance in people with Down's syndrome and dementia</article-title><source>J Intellect Disabil Res</source><year>1995</year><volume>39</volume><fpage>432</fpage><lpage>436</lpage><pub-id pub-id-type='pmid'>8555719</pub-id></element-citation></ref><ref id='B9'><label>9</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Coppus</surname><given-names>AM</given-names></name><name><surname>Evenhuis</surname><given-names>HM</given-names></name><name><surname>Verberne</surname><given-names>GJ</given-names></name><name><surname>Visser</surname><given-names>FE</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Eikelenboom</surname><given-names>P</given-names></name><name><surname>van Gool</surname><given-names>WA</given-names></name><name><surname>Janssens</surname><given-names>AC</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name></person-group><article-title>Survival in elderly persons with Down syndrome</article-title><source>J Am Geriatr Soc</source><year>2008</year><volume>56</volume><fpage>2311</fpage><lpage>2316</lpage><pub-id pub-id-type='pmid'>19093931</pub-id></element-citation></ref><ref id='B10'><label>10</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Prasher</surname><given-names>VP</given-names></name></person-group><article-title>Down's syndrome, longevity, and Alzheimer's disease</article-title><source>Br J Psychiatry</source><year>1993</year><volume>162</volume><fpage>711</fpage><pub-id pub-id-type='pmid'>8149134</pub-id></element-citation></ref><ref id='B11'><label>11</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Thase</surname><given-names>ME</given-names></name></person-group><article-title>Longevity and mortality in Down's syndrome</article-title><source>J Ment Defic Res</source><year>1982</year><volume>26</volume><fpage>177</fpage><lpage>192</lpage><pub-id pub-id-type='pmid'>6217345</pub-id></element-citation></ref><ref id='B12'><label>12</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McCarron</surname><given-names>M</given-names></name><name><surname>McCallion</surname><given-names>P</given-names></name><name><surname>Reilly</surname><given-names>E</given-names></name><name><surname>Mulryan</surname><given-names>N</given-names></name></person-group><article-title>A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome</article-title><source>J Intellect Disabil Res</source><year>2014</year><volume>58</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type='pmid'>23902161</pub-id></element-citation></ref><ref id='B13'><label>13</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Nieuwenhuis-Mark</surname><given-names>RE</given-names></name></person-group><article-title>Diagnosing Alzheimer's dementia in Down syndrome: problems and possible solutions</article-title><source>Res Dev Disabil</source><year>2009</year><volume>30</volume><fpage>827</fpage><lpage>838</lpage><pub-id pub-id-type='pmid'>19269132</pub-id></element-citation></ref><ref id='B14'><label>14</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Prasher</surname><given-names>V</given-names></name><name><surname>Farooq</surname><given-names>A</given-names></name><name><surname>Holder</surname><given-names>R</given-names></name></person-group><article-title>The Adaptive Behaviour Dementia Questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer's disease in adults with Down syndrome</article-title><source>Res Dev Disabil</source><year>2004</year><volume>25</volume><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type='pmid'>15193672</pub-id></element-citation></ref><ref id='B15'><label>15</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Dauwels</surname><given-names>J</given-names></name><name><surname>Vialatte</surname><given-names>F</given-names></name><name><surname>Cichocki</surname><given-names>A</given-names></name></person-group><article-title>Diagnosis of Alzheimer's disease from EEG signals: where are we standing?</article-title><source>Curr Alzheimer Res</source><year>2010</year><volume>7</volume><fpage>487</fpage><lpage>505</lpage><pub-id pub-id-type='pmid'>20455865</pub-id></element-citation></ref><ref id='B16'><label>16</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Murata</surname><given-names>T</given-names></name><name><surname>Koshino</surname><given-names>Y</given-names></name><name><surname>Omori</surname><given-names>M</given-names></name><name><surname>Murata</surname><given-names>I</given-names></name><name><surname>Nishio</surname><given-names>M</given-names></name><name><surname>Horie</surname><given-names>T</given-names></name><name><surname>Isaki</surname><given-names>K</given-names></name></person-group><article-title>Quantitative EEG study on premature aging in adult Down's syndrome</article-title><source>Biol Psychiatry</source><year>1994</year><volume>35</volume><fpage>422</fpage><lpage>425</lpage><pub-id pub-id-type='pmid'>8018790</pub-id></element-citation></ref><ref id='B17'><label>17</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Deb</surname><given-names>S</given-names></name><name><surname>Hare</surname><given-names>M</given-names></name><name><surname>Prior</surname><given-names>L</given-names></name><name><surname>Bhaumik</surname><given-names>S</given-names></name></person-group><article-title>Dementia screening questionnaire for individuals with intellectual disabilities</article-title><source>Br J Psychiatry</source><year>2007</year><volume>190</volume><fpage>440</fpage><lpage>444</lpage><pub-id pub-id-type='pmid'>17470960</pub-id></element-citation></ref><ref id='B18'><label>18</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Hort</surname><given-names>J</given-names></name><name><surname>O'Brien</surname><given-names>JT</given-names></name><name><surname>Gainotti</surname><given-names>G</given-names></name><name><surname>Pirttila</surname><given-names>T</given-names></name><name><surname>Popescu</surname><given-names>BO</given-names></name><name><surname>Rektorova</surname><given-names>I</given-names></name><name><surname>Sorbi</surname><given-names>S</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name></person-group><article-title>EFNS guidelines for the diagnosis and management of Alzheimer's disease</article-title><source>Eur J Neurol</source><year>2010</year><volume>17</volume><fpage>1236</fpage><lpage>1248</lpage><pub-id pub-id-type='pmid'>20831773</pub-id></element-citation></ref><ref id='B19'><label>19</label><element-citation publication-type='book'><person-group person-group-type='author'><collab>World Health Organization</collab></person-group><source>The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research</source><year>1993</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id='B20'><label>20</label><element-citation publication-type='book'><person-group person-group-type='author'><collab>American Psychiatric Association</collab></person-group><source>Diagnostic and Statistical Manual of Mental Disorders</source><year>2000</year><publisher-loc>Washington</publisher-loc><publisher-name>American Psychiatric Association</publisher-name></element-citation></ref><ref id='B21'><label>21</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McKhann</surname><given-names>G</given-names></name><name><surname>Drachman</surname><given-names>D</given-names></name><name><surname>Folstein</surname><given-names>M</given-names></name><name><surname>Katzman</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>D</given-names></name><name><surname>Stadlan</surname><given-names>EM</given-names></name></person-group><article-title>Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease</article-title><source>Neurology</source><year>1984</year><volume>34</volume><fpage>939</fpage><lpage>944</lpage><pub-id pub-id-type='pmid'>6610841</pub-id></element-citation></ref><ref id='B22'><label>22</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Aylward</surname><given-names>EH</given-names></name><name><surname>Burt</surname><given-names>DB</given-names></name><name><surname>Thorpe</surname><given-names>LU</given-names></name><name><surname>Lai</surname><given-names>F</given-names></name><name><surname>Dalton</surname><given-names>A</given-names></name></person-group><article-title>Diagnosis of dementia in individuals with intellectual disability</article-title><source>J Intellect Disabil Res</source><year>1997</year><volume>41</volume><fpage>152</fpage><lpage>164</lpage><pub-id pub-id-type='pmid'>9161927</pub-id></element-citation></ref><ref id='B23'><label>23</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Oldfield</surname><given-names>RC</given-names></name></person-group><article-title>The assessment and analysis of handedness: the Edinburgh inventory</article-title><source>Neuropsychologia</source><year>1971</year><volume>9</volume><fpage>97</fpage><lpage>113</lpage><pub-id pub-id-type='pmid'>5146491</pub-id></element-citation></ref><ref id='B24'><label>24</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Jousmäki</surname><given-names>V</given-names></name><name><surname>Helkala</surname><given-names>EL</given-names></name><name><surname>Vanhanen</surname><given-names>M</given-names></name><name><surname>Majuri</surname><given-names>S</given-names></name><name><surname>Kaski</surname><given-names>M</given-names></name><name><surname>Hartikainen</surname><given-names>P</given-names></name><name><surname>Riekkinen</surname><given-names>P</given-names><suffix>Sr</suffix></name></person-group><article-title>Age-related cognitive decline and electroencephalogram slowing in Down's syndrome as a model of Alzheimer's disease</article-title><source>Neuroscience</source><year>1993</year><volume>53</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type='pmid'>8469312</pub-id></element-citation></ref><ref id='B25'><label>25</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Visser</surname><given-names>FE</given-names></name><name><surname>Kuilman</surname><given-names>M</given-names></name><name><surname>Oosting</surname><given-names>J</given-names></name><name><surname>Overweg</surname><given-names>J</given-names></name><name><surname>van Wijk</surname><given-names>J</given-names></name><name><surname>van Huffelen</surname><given-names>AC</given-names></name></person-group><article-title>Use of electroencephalography to detect Alzheimer's disease in Down's syndrome</article-title><source>Acta Neurol Scand</source><year>1996</year><volume>94</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type='pmid'>8891053</pub-id></element-citation></ref><ref id='B26'><label>26</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Evenhuis</surname><given-names>HM</given-names></name></person-group><article-title>The natural history of dementia in Down's syndrome</article-title><source>Arch Neurol</source><year>1990</year><volume>47</volume><fpage>263</fpage><lpage>267</lpage><pub-id pub-id-type='pmid'>2138013</pub-id></element-citation></ref><ref id='B27'><label>27</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Menendez</surname><given-names>M</given-names></name></person-group><article-title>Down syndrome, Alzheimer's disease and seizures</article-title><source>Brain Dev</source><year>2005</year><volume>27</volume><fpage>246</fpage><lpage>252</lpage><pub-id pub-id-type='pmid'>15862185</pub-id></element-citation></ref><ref id='B28'><label>28</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Krinsky-McHale</surname><given-names>SJ</given-names></name><name><surname>Silverman</surname><given-names>W</given-names></name></person-group><article-title>Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis</article-title><source>Dev Disabil Res Rev</source><year>2013</year><volume>18</volume><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type='pmid'>23949827</pub-id></element-citation></ref><ref id='B29'><label>29</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Azizeh</surname><given-names>BY</given-names></name><name><surname>Head</surname><given-names>E</given-names></name><name><surname>Ibrahim</surname><given-names>MA</given-names></name><name><surname>Torp</surname><given-names>R</given-names></name><name><surname>Tenner</surname><given-names>AJ</given-names></name><name><surname>Kim</surname><given-names>RC</given-names></name><name><surname>Lott</surname><given-names>IT</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><article-title>Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs</article-title><source>Exp Neurol</source><year>2000</year><volume>163</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type='pmid'>10785449</pub-id></element-citation></ref><ref id='B30'><label>30</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Harciarek</surname><given-names>M</given-names></name><name><surname>Cosentino</surname><given-names>S</given-names></name></person-group><article-title>Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes</article-title><source>Int Rev Psychiatry</source><year>2013</year><volume>25</volume><fpage>178</fpage><lpage>196</lpage><pub-id pub-id-type='pmid'>23611348</pub-id></element-citation></ref></ref-list></back><floats-group><fig orientation='portrait' id='F1' position='float'><label>Fig. 1</label><caption><p>Illustration of the outcome of the qEEG analysis.</p></caption><graphic xlink:href='dee-0005-0404-g01'></graphic></fig><fig orientation='portrait' id='F2' position='float'><label>Fig. 2</label><caption><p>Mean scores (Hz) of centroid frequency in the theta-1 band for all the regions investigated in patients and control subjects. A decrease in centroid frequency is evident globally in patients as compared to control subjects and significantly different in several areas of the brain (frontotemporal on both sides and parietal on the left side). * Significantly different from control subjects at p &lt; 0.05 (t test).</p></caption><graphic xlink:href='dee-0005-0404-g02'></graphic></fig><fig orientation='portrait' id='F3' position='float'><label>Fig. 3</label><caption><p>Means of centroid frequency recorded in the frontotemporal region (F7-T3) on the left side for the theta-1 band compared to the total score on the DSQIID. A negative correlation is seen between the quantity of symptoms of dementia and the mean of the centroid frequency for the theta-1 band. ○ = Control subjects; ● = DS-AD subjects.</p></caption><graphic xlink:href='dee-0005-0404-g03'></graphic></fig><fig orientation='portrait' id='F4' position='float'><label>Fig. 4</label><caption><p>Correlation between the mean of the centroid frequency in the theta-1 band and the total score on the DSQIID using multiple linear regression analysis in all the regions of the brain investigated. Pearson's correlation coefficient is shown in the vertical bar, correlating to a shift in colour. The correlation between a high quantity of symptoms of dementia and a decrease in the centroid frequency for the theta-1 band is evident globally and most pronounced frontotemporal on the left side.</p></caption><graphic xlink:href='dee-0005-0404-g04'></graphic></fig><table-wrap orientation='portrait' id='T1' position='float'><label>Table 1</label><caption><p>Clinical data on the patients and controls with DS</p></caption><table rules='groups' frame='hsides'><thead><tr valign='top'><th colspan='1' rowspan='1'></th><th colspan='1' rowspan='1' align='left'>Patients (DS-AD)</th><th colspan='1' rowspan='1' align='left'>Controls (DS)</th><th colspan='1' rowspan='1' align='left'>p value</th></tr></thead><tbody><tr><td colspan='1' rowspan='1' align='left'>Subjects, n (%)</td><td colspan='1' rowspan='1' align='left'>21 (57)</td><td colspan='1' rowspan='1' align='left'>16 (43)</td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'>Mean age (range), years</td><td colspan='1' rowspan='1' align='left'>52.5 (40 – 63)</td><td colspan='1' rowspan='1' align='left'>48.5 (38 – 68)</td><td colspan='1' rowspan='1' align='left'>p = 0.099<sup>1</sup></td></tr><tr><td colspan='1' rowspan='1' align='left'>Male-female ratio, n</td><td colspan='1' rowspan='1' align='left'>18:3</td><td colspan='1' rowspan='1' align='left'>16:10</td><td colspan='1' rowspan='1' align='left'>p = 0.103<sup>2</sup></td></tr><tr><td colspan='1' rowspan='1' align='left'>Handedness (L/R), n</td><td colspan='1' rowspan='1' align='left'>2/19</td><td colspan='1' rowspan='1' align='left'>2/14</td><td colspan='1' rowspan='1'></td></tr><tr><td colspan='1' rowspan='1' align='left'>Mean DSQIID score ± SD</td><td colspan='1' rowspan='1' align='left'>21.7 ± 6.2</td><td colspan='1' rowspan='1' align='left'>2.8 ± 3.0</td><td colspan='1' rowspan='1' align='left'>p &lt; 0.001<sup>3</sup></td></tr></tbody></table><table-wrap-foot><fn id='T1F1'><label>1</label><p>t test.</p></fn><fn id='T1F2'><label>2</label><p>χ<sup>2</sup> test.</p></fn><fn id='T1F3'><label>3</label><p>Mann-Whitney U test.</p></fn></table-wrap-foot></table-wrap></floats-group></article></PAPER>